RTOG 0017: A phase i trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer

Hak Choy, Anshu K. Jain, Jennifer Moughan, Walter Curran, Gary Whipple, William F. Demas, David S. Ettinger

Radiation Oncology
Radiation Oncology - Administration

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'RTOG 0017: A phase i trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

RTOG 0017: A phase i trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer

Fingerprint

Medicine & Life Sciences